Related Experiment Video
Updated: Jun 17, 2026

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Health care resource utilization in patients with active epilepsy
Tobias Kurth1, Barbara E Lewis, Alexander M Walker
1INSERM Unit 708 - Neuroepidemiology, Paris, France.
Active epilepsy affects 3.4 per 1,000 people. Most health care resource utilization (HRU) in epilepsy patients is not epilepsy-related, highlighting the need for better cost analysis.
Area of Science:
- Neurology
- Health Economics
- Public Health
Background:
- Active epilepsy impacts a significant portion of the population.
- Understanding health care resource utilization (HRU) is crucial for managing epilepsy costs.
Purpose of the Study:
- To evaluate health care resource utilization (HRU) in active epilepsy.
- To identify patterns and drivers of HRU across different epilepsy types.
Main Methods:
- Analysis of Thomson-Reuters insurance databases (2005-2007) covering 14 million individuals.
- Iterative expert classification to categorize patients by epilepsy type.
- Calculation of prevalence and HRU for each epilepsy type, with distance and principal components analysis.
Main Results:
- Prevalence of active epilepsy was 3.4 per 1,000; common types include generalized convulsive epilepsy and complex partial seizures.
- Average patient HRU included 10 physician visits, 24 diagnostic procedures, and >30 drug dispensings annually.
- Nonepilepsy-related HRU constituted the majority of utilization and was the primary source of variation, with distinct patterns for specific epilepsy types like grand mal status.
Conclusions:
- Active epilepsy prevalence is lower than a history of recurrent seizures.
- Nonepilepsy-related HRU significantly influences overall utilization and cost in epilepsy patients.
- Distinguishing between epilepsy-related and unrelated care is essential for accurate economic impact studies.
More Related Videos
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
10:46Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings
Published on: September 1, 2023
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists